Evidence map›Paper›PMID 42194051›Full record

ArticleBiomolecules2026

A Liposomal Delivery System of Blueberry Anthocyanins Ameliorates Corneal Laser Injury.

Zihan Lv, Chaoran Li, Di Liang, Guangrui Chen, Mengqi Qiu, Zhiyun Meng, Ruolan Gu, Hui Gan, Zhuona Wu, Zaifu Yang and 1 more

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zihan LvAcademy of Military Medical Sciences, Beijing 100850, China.
Chaoran LiAcademy of Military Medical Sciences, Beijing 100850, China.
Di LiangAcademy of Military Medical Sciences, Beijing 100850, China.ORCID 0000-0002-8993-0436
Guangrui ChenAcademy of Military Medical Sciences, Beijing 100850, China.ORCID 0000-0002-7281-6530
Mengqi QiuAcademy of Military Medical Sciences, Beijing 100850, China.
Zhiyun MengAcademy of Military Medical Sciences, Beijing 100850, China.
Ruolan GuAcademy of Military Medical Sciences, Beijing 100850, China.
Hui GanAcademy of Military Medical Sciences, Beijing 100850, China.
Zhuona WuAcademy of Military Medical Sciences, Beijing 100850, China.
Zaifu YangAcademy of Military Medical Sciences, Beijing 100850, China.
Guifang DouAcademy of Military Medical Sciences, Beijing 100850, China.ORCID 0000-0001-5004-2194

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to develop and systematically evaluate a new lipid-based formulation of blueberry anthocyanins, which can accelerate the healing effect of the cornea. The study first successfully screened and optimized the formulation and preparation process for blueberry anthocyanin liposomes. Characterization via transmission electron microscopy and dynamic light scattering revealed uniformly distributed, near-spherical liposomes with distinct phospholipid bilayers. Key physicochemical parameters-particle size, zeta potential, encapsulation efficiency, and drug loading capacity-all met formulation standards. In vivo pharmacodynamic experiments demonstrated that topical administration of blueberry anthocyanin liposomes significantly accelerated the repair process and effectively mitigated depressional damage to the corneal epithelium in a New Zealand white rabbit corneal injury model induced by 10.6 μm mid-infrared CO

Indexed as

AnthocyaninsBlueberry PlantsCorneal InjuriesDrug Delivery SystemsLasersLiposomesAnimalsCorneaParticle SizeRabbitsAnthocyaninsLiposomesblueberry anthocyaninscorneal laser damageliposomesnanostructures

Identifiers

PMID42194051
PMCPMC13204816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.